Stem Cell Therapeutics Corp. Announces Completion of …
CALGARY, ALBERTA–(Marketwire – March 31, 2010) – Stem Cell Therapeutics Corp. (”SCT” or the “Company”) (TSX VENTURE:SSS) announced today that it closed patient enrollment of the modified Phase IIb stroke trial on March 31st, 2010 and will analyze …
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Completion of Enrollment in Key Modified REGENESIS Phase IIb Stroke Trial
Stem Cell Therapeutics Corp. Announces the Completion of the 90 Day Endpoint Period for the Last Patient Enrolled in …
Stem Cell Therapeutics Corp. Provides Update on Modified REGENESIS Phase IIb Stroke Trial